Biosimilar Inspection Modernization Act of 2025

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

• Introduced in Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Health, Education, Labor, and Pensions Committee
  Senate

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• PFIZER INC.
  for PFIZER INC. · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• PFIZER INC.
  for PFIZER INC. · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
• FIERCE GOVERNMENT RELATIONS
  for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
• PFIZER INC.
  for PFIZER INC. · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  4 filings
• SENATE
  4 filings
• Commerce, Dept of (DOC)
  3 filings
• Food & Drug Administration (FDA)
  3 filings
• U.S. Trade Representative (USTR)
  3 filings
• Executive Office of the President (EOP)
  2 filings
• Health & Human Services, Dept of (HHS)
  2 filings
• Natl Institutes of Health (NIH)
  2 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.